EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Pre-Transplant Antibiotic Exposures and Intestinal Microbiome Diversity in Allo-HSCT Recipients: A Prospective Cohort Study

Lavinia-Eugenia Lipan, Karina-Doris Vihta, Andra-Daniela Marcu, Irina Avramescu, Dumitru Jardan, Andi Palade, Anca Colita, Simona-Olimpia Dima, Ileana Constantinescu, Iuliana Iordan, Alexandra Marcoci, Oana-Gabriela Craciun und 2 weitere

Germs · 14.07.2026 · 16 (3) · 17

DOI: 10.3390/germs16030017 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Germs, online erschienen am 14.07.2026. Verfasst von Lavinia-Eugenia Lipan und 13 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EU NextGenerationEU.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intestinal microbiome dysbiosis has been associated with transplant-related mortality and graft-versus-host disease in allo-HSCT patients. We assessed how pre-transplant antibiotic and antineoplastic exposures, together with multidrug-resistant colonization, are associated with baseline gut microbiome diversity at allo-HSCT. We conducted a prospective, single-center cohort study at Fundeni Clinical Institute (Bucharest, Romania) between August 2024 and June 2025, enrolling 52 allo-HSCT recipients and 27 healthy controls. Fecal samples were collected before conditioning. Gut microbiome composition was assessed via 16S rRNA gene sequencing and analyzed using QIIME2 and R. Associations were evaluated using Wilcoxon test, multivariable linear regression, and PERMANOVA. Shannon diversity was significantly lower in patients (median 4.71, IQR 3.97–5.44) than in healthy controls (median 6.09, IQR 5.87–6.28; p < 0.001). In bivariate analyses, carbapenem (p adj = 0.02) and oxazolidinone exposure (p adj = 0.005) were associated with reduced diversity, while immunotherapy was associated with higher diversity (p adj = 0.042). Broad-spectrum penicillin (p adj = 0.062) and ESBL colonization (p adj = 0.066) did not reach significance. In the multivariable antibiotic model, although the overall model was statistically significant (model p = 0.039), no individual antibiotic class remained significantly associated with Shannon diversity after adjustment for co-exposures. Beta diversity differed modestly with carbapenem exposure (R2 = 0.033, p = 0.019). Pre-transplant antibiotic exposures were associated with lower gut microbiome diversity at allo-HSCT admission, with patterns consistent with a cumulative rather than a class-specific association. These findings support antibiotic stewardship in pre-transplant care.

Förderung

  • EU NextGenerationEU

Zitieren

APA

Lipan, L., Vihta, K., Marcu, A., Avramescu, I., Jardan, D., Palade, A., Colita, A., Dima, S., Constantinescu, I., Iordan, I., Marcoci, A., Craciun, O., Negulescu, C., & Tănase, A. D. (2026). Pre-Transplant Antibiotic Exposures and Intestinal Microbiome Diversity in Allo-HSCT Recipients: A Prospective Cohort Study. Germs, 16(3), 17. https://doi.org/10.3390/germs16030017

Vancouver

Lipan L, Vihta K, Marcu A, Avramescu I, Jardan D, Palade A, et al. Pre-Transplant Antibiotic Exposures and Intestinal Microbiome Diversity in Allo-HSCT Recipients: A Prospective Cohort Study. Germs. 2026;16(3):17. doi:10.3390/germs16030017

BibTeX
@article{Lipan2026,
  author = {Lipan, Lavinia-Eugenia and Vihta, Karina-Doris and Marcu, Andra-Daniela and Avramescu, Irina and Jardan, Dumitru and Palade, Andi and Colita, Anca and Dima, Simona-Olimpia and Constantinescu, Ileana and Iordan, Iuliana and Marcoci, Alexandra and Craciun, Oana-Gabriela and Negulescu, Cristina and Tănase, Alina Daniela},
  title = {Pre-Transplant Antibiotic Exposures and Intestinal Microbiome Diversity in Allo-HSCT Recipients: A Prospective Cohort Study},
  journal = {Germs},
  year = {2026},
  volume = {16},
  number = {3},
  pages = {17},
  doi = {10.3390/germs16030017}
}
Kostenlos starten →